Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

1. Avian influenza: guidance for managing human cases

Avian influenza: guidance for managing human cases Avian influenza: guidance for managing human cases - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Avian influenza: guidance for managing human cases Information to assist with the management of possible and confirmed human (...) cases of avian influenza. Published 12 February 2014 Last updated 13 January 2020 — From: Documents Ref: PHE publications gateway number: GW-1025 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format

2020 Public Health England

2. Avian influenza A(H5N6): risk assessment

Avian influenza A(H5N6): risk assessment Avian influenza A(H5N6): risk assessment - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Avian influenza A(H5N6): risk assessment The risk to UK residents travelling to China is very low. This update includes information and advice (...) for travellers and clinicians. Published 15 February 2016 Last updated 8 January 2020 — From: Documents Ref: GW-997 HTML Details This update includes: background information risk assessment advice for travellers advice for clinicians The risk to UK residents travelling to China is very low. Published 15 February 2016 Last updated 8 January 2020 8 January 2020 Updated 'Avian influenza A(H5N6): risk assessment.' 17 April 2018 Updated 'Avian influenza A(H5N6): risk assessment.' 21 April 2017 Updated version

2020 Public Health England

3. Cell-Mediated Immune Responses After Influenza Vaccination of Solid Organ Transplant Recipients: Secondary Outcomes Analyses of a Randomized Controlled Trial

Cell-Mediated Immune Responses After Influenza Vaccination of Solid Organ Transplant Recipients: Secondary Outcomes Analyses of a Randomized Controlled Trial Cell-Mediated Immune Responses After Influenza Vaccination of Solid Organ Transplant Recipients: Secondary Outcomes Analyses of a Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go (...) your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation J Infect Dis Actions , 221 (1), 53-62 2020 Jan 1 Cell-Mediated Immune Responses After Influenza Vaccination of Solid Organ Transplant Recipients: Secondary Outcomes Analyses of a Randomized Controlled Trial

2020 EvidenceUpdates

4. Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta-analysis Full Text available with Trip Pro

respiratory syndrome[MeSH Terms] #8 flu OR influenza OR grippe OR SARS OR “severe acute respiratory syndrome”[Text Word] #9 #7 OR #8 #10 #3 AND #6 AND #9 2.3 Study selection and data extraction Two reviewers independently screened the articles based on the titles, abstracts and full texts. Then, two reviewers independently exacted the following data from included studies: first author, publication year, country, disease, details of study population and intervention, study design, sample size, settings (...) and fit loosely to the user's face. 5,6 Although surgical masks cannot prevent inhalation of small airborne particles, both of them can protect users from large droplets and sprays. , There are conflicting recommendations for severe acute respiratory syndrome (SARS) and pandemic influenza: the World Health Organization (WHO) recommends using masks in low‐risk situations and respirators in high‐risk situations, but the Centers for Disease Control and Prevention (CDC) recommends using respirators

2020 Covid-19 Ad hoc papers

5. Influenza communication guide: How to increase influenza vaccination uptake and promote preventive measures to limit its spread

materials to provide key audiences with information on seasonal influenza and encourage vaccination and the adoption of good hygiene practices. The toolkit guidance also includes suggested tactics for getting the message across to different audiences. Moreover, a logo has been created (‘Against the flu’) which can be used in conjunction with national initiatives at various events. Types of materials Prototype materials contained in this toolkit provide a hierarchy of information ranging from the concise (...) t the flu’ c an be tr an s l at ed into local languages. Posters The poster presents basic facts on influenza and key preventive messages which can be read and understood quickly. More detailed content can be made available to target audiences via factsheets and brochures but can also appear on websites and in other materials. Factsheets The tw o-p ag e f actsheets (1 30 x 2 50 mm) pr o v ide key information presented very synthetically. A lthough they c ont ain mor e t e xt th an the po s t er

2019 European Centre for Disease Prevention and Control - Technical Guidance

6. Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis Full Text available with Trip Pro

Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis Corticosteroids may be beneficial in sepsis, but uncertainty remains over their effects in severe influenza. This systematic review updates the current evidence regarding corticosteroids in the treatment of influenza and examines the effect of dose on outcome.Electronic databases (MEDLINE, EMBASE, CINAHL, LILACS, CENTRAL, and Web of Science) and trial registries were (...) ). Risk of bias assessment was consistent with potential confounding by indication. Pooled analysis of seven studies showed increased odds of hospital-acquired infection in people treated with corticosteroids (unadjusted odds ratio, 2.74; 95% CI, 1.51-4.95). Meta-regression of the effect of dose on mortality did not reveal an association, but reported doses of corticosteroids in included studies were high (mostly > 40 mg methylprednisolone [or equivalent] per day).Corticosteroid treatment in influenza

2019 EvidenceUpdates

7. Inactivated influenza vaccine: information for healthcare practitioners

for the flu season 2019 to 2020. 27 September 2018 Added new revised version of document. 8 August 2018 Added national influenza programme guidance for the inactivated influenza vaccine. 15 August 2017 Added link to slideset for the 2017 to 2018 national flu immunisation programme; for viewing and downloading. 7 August 2017 Revised guidance for the 2017 to 2018 flu season. 10 November 2016 Updated to include questions on air bubbles in pre-filled syringes and giving flu vaccine to patients taking oral (...) Inactivated influenza vaccine: information for healthcare practitioners Inactivated influenza vaccine: information for healthcare practitioners - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Inactivated

2019 Public Health England

8. Seasonal influenza: managing cases in critical care units

Seasonal influenza: managing cases in critical care units Seasonal influenza: managing cases in critical care units - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Seasonal influenza: managing cases (...) in critical care units Advice and recommendations for healthcare professionals on managing seasonal influenza cases in adult critical care units. Published 28 July 2017 Last updated 22 November 2019 — From: Documents Ref: PHE publications gateway number: GW-902 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details

2019 Public Health England

9. Zanamivir (Dectova) - influenza A or B

Zanamivir (Dectova) - influenza A or B Published 09 December 2019 1 Product update SMC2204 zanamivir 10mg/mL solution for infusion (Dectova®) GlaxoSmithKline 9 August 2019 (Issued 8 November 2019) The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS Boards and Area Drug and Therapeutic Committees (ADTCs) on its use in NHSScotland. The advice is summarised as follows: ADVICE: following an abbreviated submission zanamivir (Dectova®) is accepted (...) for use within NHSScotland. Indication under review: Treatment of complicated and potentially life-threatening influenza A or B virus infection in adult and paediatric patients (aged = 6 months) when: ? the patient’s influenza virus is known or suspected to be resistant to anti-influenza medicinal products other than zanamivir, and/or ? other anti-viral medicinal products for treatment of influenza, including inhaled zanamivir, are not suitable for the individual patient. Zanamivir should be used

2019 Scottish Medicines Consortium

10. Point of care tests for influenza and other respiratory viruses

Point of care tests for influenza and other respiratory viruses Point of care tests for influenza and other respiratory viruses - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote (...) in the General Election on 12 December. Guidance Point of care tests for influenza and other respiratory viruses Support for hospital trusts considering the introduction of point of care testing (POCT) for influenza and other respiratory viruses during winter 2019 to 2020. Published 27 November 2018 Last updated 28 October 2019 — From: Documents Ref: PHE publications gateway number: GW-846 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible

2019 Public Health England

11. Flu immunisation for early years settings including child minders

in the General Election on 12 December. Guidance Flu immunisation for early years settings including child minders Guidance for early years childcare settings on the nasal spray flu (influenza) vaccination for preschool children. Published 16 September 2016 Last updated 15 October 2019 — From: Documents Ref: PHE Publications Gateway Number 2019074 15 October 2019 Added pre-school guidance for the 2019 to 2020 flu season. 18 September 2018 Added revised guidance for early years childcare settings. 7 September (...) Flu immunisation for early years settings including child minders Flu immunisation for early years settings including child minders - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote

2019 Public Health England

12. Seasonal flu in the children and young people’s secure estate

Seasonal flu in the children and young people’s secure estate Seasonal flu in the children and young people’s secure estate - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote in the General (...) Election on 12 December. Guidance Seasonal flu in the children and young people’s secure estate Guidance for healthcare and residential staff to help them respond to individual flu cases and manage outbreaks. Published 23 November 2017 Last updated 14 October 2019 — From: Documents Ref: PHE publications gateway number: GW-803 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need

2019 Public Health England

13. Flu: information for prison and detention centre staff in England

Flu: information for prison and detention centre staff in England Flu: information for prison and detention centre staff in England - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote (...) in the General Election on 12 December. Guidance Flu: information for prison and detention centre staff in England How to respond to individual cases or outbreaks of seasonal flu, including vaccination, recommendations and managing outbreaks. Published 1 October 2013 Last updated 14 October 2019 — From: Documents Ref: PHE publications gateway number GW-802 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us

2019 Public Health England

14. Increasing Influenza and Pneumococcal Vaccination Uptake in Seniors Using Point-of-Care Informational Interventions in Primary Care in Singapore: A Pragmatic, Cluster-Randomized Crossover Trial Full Text available with Trip Pro

Increasing Influenza and Pneumococcal Vaccination Uptake in Seniors Using Point-of-Care Informational Interventions in Primary Care in Singapore: A Pragmatic, Cluster-Randomized Crossover Trial Objectives. To evaluate the effectiveness of point-of-care informational interventions in general practitioner clinics to improve influenza and pneumococcal vaccination uptake among elderly patients.Methods. We conducted a pragmatic, cluster-randomized crossover trial in 22 private general practitioner (...) in the intervention and control periods, respectively. Both influenza (5.9% vs 4.8%; P = .047) and pneumococcal (5.7% vs 3.7%; P = .001) vaccination uptake rates were higher during the intervention period compared with the control period. On multilevel logistic regression analysis, follow-up for hypertension, diabetes mellitus, hyperlipidemia, or any combination of the 3 was associated with uptake of both vaccines.Conclusions. Point-of-care informational interventions likely contributed to increased influenza

2019 EvidenceUpdates

15. Zanamivir (Dectova) - influenza

Zanamivir (Dectova) - influenza Final Appraisal Recommendation Advice No: 1219 – October 2019 Zanamivir (Dectova ® ) 10 mg/ml solution for infusion Limited submission by GlaxoSmithKline UK This product is not currently marketed in the UK In reaching the above recommendation AWMSG has taken account of the appraisal documentation prepared by the AWMSG Secretariat (reference number 4130), which includes the AWMSG Secretariat Assessment Report (ASAR), the Preliminary Appraisal Recommendation (PAR (...) ) and the applicant company’s response to the PAR, clinical expert opinion (where available), the views of patients/patient carers (where available) and the lay member perspective. This recommendation has been ratified by Welsh Government and will be considered for review every three years. Recommendation of AWMSG Zanamivir (Dectova ® ) is recommended as an option for use within NHS Wales for the treatment of complicated and potentially life-threatening influenza A or B virus infection in adult and paediatric

2019 All Wales Medicines Strategy Group

16. Recommendations for Prevention and Control of Influenza in Children, 2019–2020

of complications of influenza. Abbreviations: AAP — American Academy of Pediatrics ACIP — Advisory Committee on Immunization Practices CDC — Centers for Disease Control and Prevention CI — confidence interval FDA — US Food and Drug Administration GBS — Guillain-Barré syndrome HA — hemagglutinin HCP — health care personnel IDSA — Infectious Diseases Society of America IIV — inactivated influenza vaccine IIV3 — trivalent inactivated influenza vaccine IIV4 — quadrivalent inactivated influenza vaccine IV (...) that would notably impede vaccine delivery into the nasopharyngeal mucosa should have LAIV vaccination deferred until resolution. History of Guillain-Barré syndrome (GBS) after influenza vaccine is considered a precaution for the administration of influenza vaccines. Data on the risk of GBS after vaccination with seasonal influenza vaccine are variable and have been inconsistent across seasons. If there is an increased risk, it is likely small and primarily in adult patients. GBS is rare, especially

2019 American Academy of Pediatrics

17. Influenza: treatment and prophylaxis using anti-viral agents

using anti-viral agents Guidance on how to manage influenza (flu) using anti-viral agents. Published 23 January 2014 Last updated 8 October 2019 — From: Documents Ref: PHE publications gateway number: GW-685 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Ref: 2014422 If you use assistive technology (...) the information contained is no longer applicable. 27 January 2016 Update letter for antiviral prescribing when A(H1N1)pdm09 influenza virus is the dominant circulating strain. 1 September 2015 Updated guidance for the 2015 to 2016 flu season. 2 February 2015 This version (5.1) updates version 5.0 (October 2014) with revised guidance on choice of antivirals in severely immunocompromised individuals. 5 November 2014 The following have been uploaded; The use of antivirals for the treatment and prophylaxis

2019 Public Health England

18. Influenza-like illness (ILI): managing outbreaks in schools

Influenza-like illness (ILI): managing outbreaks in schools Influenza-like illness (ILI): managing outbreaks in schools - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Influenza-like illness (ILI): managing (...) outbreaks in schools Guidance for local PHE Centre health protection teams about assessing and managing outbreaks of influenza-like illness in schools. Published 2 October 2018 Last updated 26 September 2019 — From: Documents Ref: PHE publications gateway number: GW-688 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use

2019 Public Health England

19. Vaccine recommendations for children and youth for the 2019/2020 influenza season

Vaccine recommendations for children and youth for the 2019/2020 influenza season The Canadian Paediatric Society continues to encourage annual influenza vaccination for ALL children and youth 6 months of age and older. Recommendations from the National Advisory Committee on Immunization (NACI) for the 2019/2020 influenza season are not substantially changed from those of last season. Quadrivalent vaccine, if available, is recommended for children 6 months to 17 years of age. Either inactivated (...) influenza vaccine or live attenuated influenza vaccine may be used for children and youth 2 to 17 years of age who are not immunocompromised. However, LAIV will not be available in Canada for the 2019/2020 season. Keywords: Children; Influenza vaccine; Inactivated influenza vaccine; LAIV; NACI

2019 Canadian Paediatric Society

20. Do Corticosteroids Benefit Patients With Influenza Pneumonia? Full Text available with Trip Pro

Do Corticosteroids Benefit Patients With Influenza Pneumonia? Do Corticosteroids Benefit Patients With Influenza Pneumonia? - Annals of Emergency Medicine Email/Username: Password: Remember me Search Terms Search within Search Share this page To read this article in full, please review your options for gaining access at the bottom of the page. Article in Press Do Corticosteroids Benefit Patients With Influenza Pneumonia? x Michael Gottlieb , MD (EBEM Commentator) , x Thomas Seagraves , MD (EBEM (...) Commentator) , x Stephen R. Gore , MD (EBEM Commentator) Department of Emergency Medicine, Rush University Medical Center, Chicago, IL DOI: Publication History Published online: July 23, 2019 To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Among patients with influenza pneumonia, corticosteroids are associated with increased mortality, longer length of stay in the ICU, and higher rates of secondary infection, although there are no data from

2019 Annals of Emergency Medicine Systematic Review Snapshots